ARCHIVE #2: 999 Past MS Headlines
Patricio Reyes M.D., F.A.N.N.
Director Alzheimer's Disease and Cognitive Disorders Program
Karstein Solheim Dementia Research Chair

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
CLICK ON THE BLUE LINKS TO READ THE FULL STORIES
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr.Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director Alzheimer's Disease and
Cognitive Disorders Program

Karstein Solheim Dementia Research Chair

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director Alzheimer's Disease and Cognitive Disorders Program

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
01/23/2005 - 01/30/2005  
01/30/2005 - 02/06/2005  
02/06/2005 - 02/13/2005  
02/13/2005 - 02/20/2005  
02/20/2005 - 02/27/2005  
02/27/2005 - 03/06/2005  
03/06/2005 - 03/13/2005  
03/13/2005 - 03/20/2005  
03/20/2005 - 03/27/2005  
03/27/2005 - 04/03/2005  
04/03/2005 - 04/10/2005  
04/10/2005 - 04/17/2005  
04/17/2005 - 04/24/2005  
04/24/2005 - 05/01/2005  
05/01/2005 - 05/08/2005  
05/08/2005 - 05/15/2005  
05/15/2005 - 05/22/2005  
05/22/2005 - 05/29/2005  
05/29/2005 - 06/05/2005  
06/05/2005 - 06/12/2005  
06/12/2005 - 06/19/2005  
06/19/2005 - 06/26/2005  
06/26/2005 - 07/03/2005  
07/03/2005 - 07/10/2005  
07/10/2005 - 07/17/2005  
07/17/2005 - 07/24/2005  
07/24/2005 - 07/31/2005  
07/31/2005 - 08/07/2005  
08/07/2005 - 08/14/2005  
08/14/2005 - 08/21/2005  
08/21/2005 - 08/28/2005  
08/28/2005 - 09/04/2005  
09/04/2005 - 09/11/2005  
09/11/2005 - 09/18/2005  
09/18/2005 - 09/25/2005  
09/25/2005 - 10/02/2005  
10/02/2005 - 10/09/2005  
10/09/2005 - 10/16/2005  
10/16/2005 - 10/23/2005  
10/23/2005 - 10/30/2005  
10/30/2005 - 11/06/2005  
11/06/2005 - 11/13/2005  
11/13/2005 - 11/20/2005  
11/20/2005 - 11/27/2005  
11/27/2005 - 12/04/2005  
12/04/2005 - 12/11/2005  
12/11/2005 - 12/18/2005  
12/18/2005 - 12/25/2005  
12/25/2005 - 01/01/2006  
01/01/2006 - 01/08/2006  
01/08/2006 - 01/15/2006  
01/15/2006 - 01/22/2006  
01/22/2006 - 01/29/2006  
01/29/2006 - 02/05/2006  
02/05/2006 - 02/12/2006  
02/12/2006 - 02/19/2006  
02/19/2006 - 02/26/2006  
02/26/2006 - 03/05/2006  
03/05/2006 - 03/12/2006  
03/12/2006 - 03/19/2006  
03/19/2006 - 03/26/2006  
03/26/2006 - 04/02/2006  
04/02/2006 - 04/09/2006  
04/09/2006 - 04/16/2006  
04/16/2006 - 04/23/2006  
04/23/2006 - 04/30/2006  
04/30/2006 - 05/07/2006  
05/07/2006 - 05/14/2006  
05/14/2006 - 05/21/2006  
05/21/2006 - 05/28/2006  
05/28/2006 - 06/04/2006  
06/04/2006 - 06/11/2006  
06/11/2006 - 06/18/2006  
06/18/2006 - 06/25/2006  
06/25/2006 - 07/02/2006  
07/02/2006 - 07/09/2006  
07/09/2006 - 07/16/2006  
07/16/2006 - 07/23/2006  
07/23/2006 - 07/30/2006  
07/30/2006 - 08/06/2006  
08/06/2006 - 08/13/2006  
08/13/2006 - 08/20/2006  
08/20/2006 - 08/27/2006  
09/03/2006 - 09/10/2006  
09/10/2006 - 09/17/2006  
09/17/2006 - 09/24/2006  
09/24/2006 - 10/01/2006  
10/01/2006 - 10/08/2006  
10/08/2006 - 10/15/2006  
10/07/2012 - 10/14/2012  
07/14/2013 - 07/21/2013  
04/20/2014 - 04/27/2014  

This page is powered by Blogger. Isn't yours?

Friday, January 27

 

"University of California scientists say defects in the creation of synapses -- connections between brain cells -- may cause the onset of Alzheimer's

Health: Bad Synapse Creation Linked To Alzheimer's - The Post Chronicle: The defect in PAK enzyme signaling pathways -- vital to the creation of synapses -- is related to the loss of a protein in certain forms of mental retardation, such as Down syndrome. The University of California-Los Angeles/Department of Veterans Affairs study suggests therapies designed to address the PAK defect could treat cognitive problems in both patient populations.

"The emerging lesson is that cognitive problems in Alzheimer's disease are related to defects in the machinery controlling neuronal connections, not the lesions observed by pathologists," said principal investigator Greg Cole, a professor of medicine and neurology. "Our findings show that PAK defects in the brains of Alzheimer's patients appear sufficient to directly cause cognitive difficulties."

Thursday, January 26

 

Use your brain, halve your risk of dementia

READ MORE: "Research from UNSW provides the most convincing evidence to date that complex mental activity across people%u2019s lives significantly reduces the risk of dementia. The researchers found that such activity almost halves the incidence of dementia.

The paper, which has just been published in Psychological Medicine, is the first comprehensive review of the research in the field of %u2019brain reserve%u2019, which looks at the role of education, occupational complexity and mentally stimulating lifestyle pursuits in preventing cognitive decline. The paper integrates data from 29,000 individuals across 22 studies from around the world.

'Until now there have been mixed messages about the role of education, occupation, IQ and mentally stimulating leisure activities, in preventing cognitive decline. Now the results are much clearer,' said the lead author, Dr Michael Valenzuela, from the School of Psychiatry at UNSW. 'It is a case of %u2019use it or lose it%u2019. If you increase your brain reserve over your lifetime, you seem to lessen the risk of Alzheimer%u2019s and other neurodegenerative diseases.'

The key conclusion is that individuals with high brain reserve have a 46 percent decreased risk of dementia, compared to those with low brain reserve. All the studies assessed agreed that mentally stimulating leisure activities, even in late life, are associated with a protective effect.

'This suggests that brain reserve is not a static property, nor that it is determined by early life experiences such as level of education, socio-economic deprivation or poor nutrition,' said Dr Valenzuela. 'It is never too late to build brain reserve.'

Dr Valenzuela%u2019s previous research showed that after five weeks of memory-based mental exercise, participants increased brain chemistry markers in the opposite direction to that seen in Alzheimer%u2019s disease. 'The interesting point here is that this change was concentrated to the hippocampus, a part of the brain first affected in dementia,' said Dr Valenzuela.

This is consistent with studies of brain reserve in mice, where some of the animals were %u2019hothoused%u2019 in stimulating environments. These mice had changes in the microstructure of their brains, compared with the controls.
"

Wednesday, January 25

 

ABC News: Study: Alzheimer's Medications Help, but Just a Little

CLICK TO READ MORE: "A new review of past clinical trials confirmed what many doctors already suspected: Three drugs that treat Alzheimer's disease %u2014 Aricept, Razadyne and Exelon %u2014 provide only a small benefit to patients.

The review, published in this month's issue of The Cochrane Library, evaluated 13 high-quality studies involving more than 7,000 patients. All three drugs made equally small improvements in the patients' mental functioning and in their ability to carry out everyday activities.

The results of this review confirm what past studies have shown %u2014 that the drugs have a modest effect. However, doctors' opinions vary about the usefulness of the drugs. Some said they believe the drugs help patients while other doctors believe they bring little benefit."

 

Brain Abnormality Found In Alzheimer’s Disease Related to Gait Impairment in Older Persons

CLICK TO READ MORE: "Results Suggest Alzheimer's Disease May Be More Common than Previously Recognized
A new study from Rush University MedicalCenter helps explain why gait problems are often progressive in old age and related to risk of dementia and death.

The study, published in the January issue of the Annals of Neurology, found that neurofibrillary tangles in the substantia nigra, a part of the brain that is subject to cell loss in Parkinson's disease, are associated with gait impairment in older persons with and without dementia. Neurofibrillary tangles are a classic brain abnormality seen in Alzheimer's disease. The more tangle pathology in the substantia nigra, the more impaired the person's gait was before death.

'Older persons without Parkinson's disease often exhibit parkinsonian signs, such as difficulty with walking and balance (gait impairment), slowness in movements, rigidity and tremor,' said study author Dr. Julie Schneider of the Rush Alzheimer's Disease Center. 'The mild parkinsonian signs associated with aging have been historically viewed simply as an expected sign of aging rather than a disease process. Previous studies have shown that at least one of these signs, gait impairment, has harmful effects in older persons, and our current study suggests why this may be the case.'"

Tuesday, January 24

 

Apple juice may protect memory in old age

READ MORE: "Consuming apple juice may protect against cell damage that contributes to age-related memory loss, conclude researchers investigating the benefits in mice.....They believe their results are down to the rich antioxidant levels in concentrated apple juice.....While studies in humans are needed to confirm the benefit to ageing people, the new research adds to previous evidence that fruit and vegetable intake might be good for an ageing brain."

 

ALZHEIMER'S PROBLEMS: Search Continues for Missing Woman with Alzheimer's


KYW Newsradio 1060 - CLICK TO READ MORE: "Police and volunteer firefighters are looking for an 80-year-old woman who is suffering from Alzheimer's Disease."

 

CBS: Man Suffering From Alzheimer's Found

READ MORE: "A 73-year-old man suffering from Alzheimers, who was last seen Friday, has been found."

 

Black Currants May Help Thwart Alzheimer's - Forbes.com

READ MORE: "Compounds in black currants
may help protect against Alzheimer's disease, according to a
study in the current issue of Chemistry & Industry
magazine.

Researchers found that these compounds -- anthocyanins and
polyphenolics -- had a strong protective effect in cultured
neuronal cells. Darker black currants contain more anthocyanins and
are likely to be more potent.

'These compounds also work in hippocampal cells taken
straight from the brain,' researcher James Joseph of Tufts
University said in a prepared statement. He said these protective
effects will likely be reproduced in the human body and that these
compounds may prevent or significantly delay the onset of
Alzheimer's.
"

 

Breaking News: Axonyx Completes First Phase I Trial with Posiphen for Alzheimer's Disease Progression

READ MORE: "Axonyx Inc. announced today completion of the ascending single dose Phase I trial with Posiphen(TM), in clinical development for the treatment of Alzheimer's disease progression.

This double-blind, placebo controlled study of Posiphen in healthy
men and women sought to establish well tolerated doses. Posiphen
appears to be well tolerated at single doses up to and including 80mg.
Blood levels of Posiphen associated with this study were higher than
those associated with beneficial effects on beta-amyloid metabolism in
animal models. The build-up of beta-amyloid (A beta) is generally
believed to be causative of the dementia of Alzheimer's disease. No
serious adverse events were reported at any dose level."

 

Doctors protest against 'cruel' ruling on Alzheimer's drugs


READ MORE: "Doctors may refuse to implement new guidelines on drugs for patients in the early stages of Alzheimer's disease, leading psychiatrists said yesterday."

 

ALZHEIMERS PROBLEMS: Philanthropist's estate becomes focus of legal battle

READ MORE: "The descendants of philanthropist James H. Binger are locked in a bitter legal battle against his longtime companion over what should become of a large chunk of his fortune. Binger made Jane K. Mauer a beneficiary in his will shortly before he died in late 2004, at age 88. 'We were in love, we were confidants, we traveled the world together,' she said. But his children and grandchildren fear he was manipulated into changing his will and giving the Minneapolis woman property worth millions of dollars. They contend he was suffering from Alzheimer's disease or was otherwise impaired when he gave Mauer, now 60, downtown building and other property"

 

New compound stops brain cell degeneration in Alzheimer's disease

READ MORE...Northwestern University : "Drug discovery researchers at Northwestern University have developed a novel orally administered compound specifically targeted to suppress brain cell inflammation and neuron loss associated with Alzheimer%u2019s disease.

The compound is also rapidly absorbed by the brain and is non-toxic %u2013 important considerations for a central nervous system drug that might need to be taken for extended periods.

As described in the Jan. 11 issue of the Journal of Neuroscience, the compound, called"

Monday, January 23

 

!!!! Light Exercise Goes a Long Way to Slow Dementia - New York Times

New York Times: "A modest amount of exercise - as few as three sessions a week - may reduce the risk of dementia in people over 65, new research shows.
From a group of 2,581 participants in a health maintenance organization in Seattle, researchers selected 1,740 people over 65 who showed no evidence of mental decline. They interviewed the subjects about their exercise habits, assessed their general health and then traced their progress for an average of about six years, periodically testing their memory and other mental abilities.
By the end of the study, published last week in Annals of Internal Medicine, 158 had developed some kind of dementia and about 400 had withdrawn from the study or died.
People who exercised more than three times a week developed dementia at a rate of 13 per 1,000 patient-years, compared with 19.7 per 1,000 patient-years for those who exercised less. (A thousand patient-years is the equivalent of 100 patients observed over a period of 10 years.)
The authors acknowledge that their data depend on self-reports, which are not always reliable, that they did not measure exercise intensity, and that although they controlled for diet supplement use, smoking, alcohol use, education and other diseases, other factors may still influence their results.
Still, Dr. Eric B. Larson, director of the Group Health Cooperative's Center for Health Studies in Seattle and the lead author on the paper, said: 'It's a robust study. Low levels of exercise cause a 30 to 40 percent reduction in risk for dementia. If someone is starting to decline, it looks like exercise may significantly help.'



"

 

!!!! Light Exercise Goes a Long Way to Slow Dementia - New York Times

New York Times: "A modest amount of exercise - as few as three sessions a week - may reduce the risk of dementia in people over 65, new research shows.
From a group of 2,581 participants in a health maintenance organization in Seattle, researchers selected 1,740 people over 65 who showed no evidence of mental decline. They interviewed the subjects about their exercise habits, assessed their general health and then traced their progress for an average of about six years, periodically testing their memory and other mental abilities.
By the end of the study, published last week in Annals of Internal Medicine, 158 had developed some kind of dementia and about 400 had withdrawn from the study or died.
People who exercised more than three times a week developed dementia at a rate of 13 per 1,000 patient-years, compared with 19.7 per 1,000 patient-years for those who exercised less. (A thousand patient-years is the equivalent of 100 patients observed over a period of 10 years.)
The authors acknowledge that their data depend on self-reports, which are not always reliable, that they did not measure exercise intensity, and that although they controlled for diet supplement use, smoking, alcohol use, education and other diseases, other factors may still influence their results.
Still, Dr. Eric B. Larson, director of the Group Health Cooperative's Center for Health Studies in Seattle and the lead author on the paper, said: 'It's a robust study. Low levels of exercise cause a 30 to 40 percent reduction in risk for dementia. If someone is starting to decline, it looks like exercise may significantly help.'



"